During the past decade, University of Cincinnati College of Medicine conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 14 clinical trials were completed, i.e. on average, 58.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 7 clinical trials were completed. i.e. 63.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Cincinnati College of Medicine" #1 sponsor was "University of Cincinnati" with 4 trials, followed by "Aerin Medical" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Health Decisions" with 2 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Cincinnati College of Medicine" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 3 trials as a collaborator, "American Academy of Neurology" with 1 trials as a collaborator, "Case Western Reserve University" with 1 trials as a collaborator, "Christiana Care Health Services" with 1 trials as a collaborator and "Foundation for Orthopedic Trauma" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "University of Cincinnati College of Medicine" are "Fibromyalgia" (3 trials), "Stroke" (3 trials), "Chronic Stroke" (2 trials), "Contraception" (2 trials) and "Gait, Hemiplegic" (2 trials). Many other conditions were trialed in "University of Cincinnati College of Medicine" in a lesser frequency.

Most popular intervention types in "University of Cincinnati College of Medicine" are "Drug" (26 trials), "Device" (9 trials), "Other" (4 trials), "Behavioral" (2 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Backward Locomotion Treadmill Training (BLTT)" (2 trials), "Galcanezumab" (2 trials), "Sham" (2 trials) and "0.5% ropivacaine" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Cincinnati College of Medicine" are 40 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "University of Cincinnati College of Medicine". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in University of Cincinnati College of Medicine, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of Cincinnati College of Medicine, 2 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 13 trials that are defined as “Not Applicable".